Clinical Trial Update: Siemens Biomarker Multi-modality [NA]

View source ↗

Summary

Recruiting update for a multi-modality biomarker clinical trial investigating fatty liver disease at Duke University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: Duke University | Conditions: Fatty Liver, Hepatic Steatosis | NA | Status: RECRUITING